Stockreport

89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]

89bio, Inc.  (ETNB) 
Last 89bio, inc. earnings: 3/18 04:05 pm Check Earnings Report
PDF – Long-term data from Phase 2b ENLIVEN trial demonstrated sustained benefits of pegozafermin at week 48 in patients with advanced NASH, which was consistent across pati [Read more]